维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Rivory"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Clinical pharmacokinetics of docetaxel显示文摘	Clarke SJ Rivory LP	1999	Clinical Pharmacokinetics1999，36，12：	1
2	Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells显示文摘	Zhang M Boyer M Rivory L	2004	Int J Radiat Oncol Biol Phys2004，58，2：	1
3	Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients显示文摘	Li K M Rivory L P Clarke S J	2005	J Chromatogr B Analyt Technol Biomed Life Sci2005，820，1：	1
4	Hepatic disposition of neurotoxins and pesticides显示文摘	Yang MC McLean AJ Rivory LP	2000	Pharmacol Toxicol2000，87，：	1
5	Solid-Phase Extraction ( SPE ) Techniques for Sample Preparation in Clinical and Pharmaceutical Analysis: A Brief Overview 显示文摘	Li KM Rivory LP Clarke SJ	2006	Curr Pharma Anal2006，2，2：	1
6	The erythromycin breath test for the prediction of drug clearance显示文摘	Rivory LP Slaviero KA Hoskins JM	2001	Clin Pharmacokinet2001，40，3：	1
7	Synthesis of optical multilayer systems using genetic algorithms显示文摘	MARTIN S RIVORY J SCHOENAUER M	1995	Applied Optics1995，34，13：	1
8	Temporary dumping syndrome after gastric peroral endoscopic myotomy: should we control the glycemia?显示文摘	Louazon T Rivory J Roman S et at	2015	Endoscopy2015，，：	1
9	Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chro- matography显示文摘	RIVORY LP CLARKE SJ BOYER M	2001	J Chromatogr B Biomed Sci Appl2001，765，2：	1
10	Clinical and preclinical pharmacokinetics of raltitrexed显示文摘	Clarke S J Beale PJ Rivory LP		0，，06：	1
11	Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients显示文摘	SHARMA R HOSKINS J M RIVORY L P	2008	Clin Cancer Res2008，14，3：	1
12	Trace analysis of SN-38 in human plasma by high-performance liquid chromatography显示文摘	RIVORY LP FINDLAY M CLARKE S	1998	J Chromatogr B1998，714，2：	1
13	Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog 显示文摘	Pond SM Rivory LP Hampson EC	1993	J Toxieol Clin Toxicol1993，31，2：	1
14	Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog 显示文摘	POND S M RIVORY L P HAMPSON E C	1993	J Toxicol Clin Toxicol1993，31，2：	1
15	Kinetics of toxic doses ff paraquat and the effects of hemoperfusion in the dog 显示文摘	?ond SM Rivory LP Hampson EC	1993	J l''oxicol Clin Toxicol1993，31，2：	1
16	Oinical pharmacokinetics of docetaxe显示文摘	Clarke S J Rivory LP	1999	Clin Pharmacokinet1999，36，：	1
17	Molecular, cellular, and clinical aspects of the pharmacology of 20(S) camptothecin and its derivatives显示文摘	RIVORY L P ROBERT J	1995	J Pharmacol Ther1995，68，2：	1
18	Kinetics of the in vivo interconversion of the earboxylate and lactone forms of irinote- can ( CPT-11 ) and of its metabolite SN-38 in patients 显示文摘	RIVORY L P CHATELUT E CANAL P	1994	Cancer Res1994，54，24：	1
19	The mechanism for the inhibition of acetylcholinesterases by irinotecan( CPT- 11) 显示文摘	DODDS H M RIVORY L P	1999	Mol Pharmacol1999，56，6：	1
20	Factors affecting cytochrome P450 3A aclivity in cancer patients显示文摘	Baker SD van Schaik RH Rivory LP et at	2004	Clin Cancer Res2004，10，24：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示